Merck Drives New Innovation & Adds Capacity to Advance Next Generation Antibody-drug Conjugate ADC Therapies
- Mercks unique technology, ChetoSensar™, gives new promise to ADCs by alleviating solubility challenges - New DOLCORE™ platform increases speed-to-market ...
Drivesnextgeneration Adcs Contract Development Manufacturing Organization Merck Drives New Innovation Adds Capacity Advance Next Generation Antibody Drug Conjugate Development Manufacturing Organization
Source: zazoom.it